 |
|
| Blog results | Results 1 - 10 of about 9,425 for raloxifene breast. (0.32 seconds) |
| Sorted by relevance Sort by date |
| 14 Dec 2009 by By TARA PARKER-POPE While many kinds of cancer are resistant to such treatments, tamoxifen is well documented to prevent breast cancer in many women at high risk for it. Now another drug, raloxifene, has been shown to have a similar effect, and a class of ... Well - http://well.blogs.nytimes.com/ - References |
| 19 hours ago by Doug DiPasquale "This shows that these compounds are not toxic to normal breast tissue," Kakarala says. "Women at high risk of breast cancer right now can choose to take the drugs tamoxifen or raloxifene for prevention, but most women won't take these ... thatsfit.ca - http://www.thatsfit.ca/ |
| 14 Dec 2009 by Anna Tomova ... found to enhance the effects of curcumin, with both compounds stopping the self-renewal process of cancerous stem cells, proving that these compounds are not as toxic to normal breast tissue, as drugs like tamoxifen or raloxifene. ... Visit Bulgaria - http://visitbulgaria.info/ - References |
| 13 Dec 2009 by Don Jaide Chemotherapy drugs like tamoxifen or raloxifene, are very toxic and kill faster than some cancers. Many women in peril have refused to have naything to do with those drugs once they have tried them and felt their deleterious effects. ... Rasta Livewire - http://www.africaresource.com/rasta/ |
| 29 Oct 2009 by Legault, Maki, Resnick, Coker, Hogan, Bevers,... Conclusion Tamoxifen and raloxifene are associated with similar patterns of cognitive function in postmenopausal women at increased risk of breast cancer. Future comparisons between these findings and patterns of cognitive function in ... Journal of Clinical Oncology Current Issue - http://jco.ascopubs.org/ [ More results from Journal of Clinical Oncology Current Issue ] |
| 14 Dec 2009 by vermont “Women at high risk of breast cancer right now can choose to take the drugs tamoxifen or raloxifene for prevention, but most women won't take these drugs because there is too much toxicity,” Kakarala said. “The concept that dietary ... Health Freedom Alliance - http://blogs.healthfreedomalliance.org/ |
| 13 Nov 2009 by Margaret Polaneczky, MD (aka TBTAM) The maker of Evista (raloxifene) is targeting both docs and women, urging them to calculate their lifetime risk for breast cancer and consider taking the drug if that risk for breast cancer is increased. Since raloxifene is also ... The Blog that Ate Manhattan - http://theblogthatatemanhattan.blogspot.com/ - References |
| 10 Dec 2009 The only drugs approved now for preventing breast cancer in healthy women at higher risk are the hormone blockers tamoxifen and raloxifene. Side effects such as hot flashes, high blood pressure and a higher risk of blood clots have ... TurnTo23.com - Health News - http://www.turnto23.com/health/ |
| 9 Dec 2009 Voluntary associations in the uk lack by cross-country posting tthis drug, far coming a breast of hand grdauate. His number was first basic and ferris had to pass to head indeed in work for his chain to leave, because his change worked ... goorolaph - http://www.liveinternet.ru/users/goorolaph/ |
| 2 Nov 2009 by Kondo, M., Hoshi, S.-L., Toi, M. 'Cost saving' was suggested in our recent economic evaluation of chemoprevention of breast cancer targeting women at high risk in Japan. However, this budget impact analysis reveals that the introduction of chemoprevention appears to be ... Japanese Journal of Clinical Oncology -... - http://jjco.oxfordjournals.org/ |
Stay up to date on these results:
| Google Home - About Google Blog Search Beta - Information for Blog Authors |
